BIO-THERA SOLUTIONS, LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.9 CNY | -6.08% |
|
-6.70% | -25.07% |
| 05-10 | China Grants Clinical Trial Approval to Bio-Thera's Anti-Tumor Combination Therapy | MT |
| 04-29 | Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Bio-Thera Solutions, Ltd.
Price target over the last 5 years
History of analyst recommendation changes
56d0fc875e75d3c12bdc1c4b2.uOu1SNF-0VscNkRkFoyqFIvGbvS3AgnkKYWiFCO8ou4.6NvbEvwan29MbHdQbruaY8OLKILgTT-KRvPBJU3Vy5jzpfM7vRK1dmtYCQ~62ce17f567b0b7e7d41f8165233d0d6e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
30.9
CNY
Average target price
54
CNY
Spread / Average Target
+74.76%
High Price Target
54
CNY
Spread / Highest target
+74.76%
Low Price Target
54
CNY
Spread / Lowest Target
+74.76%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688177 Stock
- Consensus Bio-Thera Solutions, Ltd.
